Californians Stem Cell Research & Cures is categorized under Biological Research in Los Angeles, CA .
Californians Stem Cell Research & Cures was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Robert Klein at the company’s single location by writing to 438 North Gower St, Los Angeles, California CA 90004 or by phoning (323) 468-3391. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Californians Stem Cell Research & Cures |
| Contact Person: | Robert Klein |
| Address: | 438 North Gower St, Los Angeles, California 90004 |
| Phone Number: | (323) 468-3391 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Californians Stem Cell Research & Cures was started in 0 to provide professional Biological Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Robert Klein for inquiries that concern Californians Stem Cell Research & Cures by calling the company number (323) 468-3391, as your correspondence is most welcome. Additionally, the physical location of the single location of Californians Stem Cell Research & Cures can be found at the coordinates as well as the street address 438 North Gower St in Los Angeles, California 90004.
For its online presence, you may visit Californians Stem Cell Research & Cures’s website at and engage with its social media outlets through on Twitter and on Facebook.